Categories: Manufacturers (D)

Granules India Limited, 2nd Floor, 3rd Block, My Home Hub, Madhapur, Hyderabad- 500 081 (TG)

Company Name : Granules India Limited

Address : 2nd Floor, 3rd Block, My Home Hub, Madhapur, Hyderabad- 500 081 (TG)

Tel No: 91-40-30660000, 91-40-66760000

Email : mail@granulesindia.com

Website : http://www.granulesindia.com/

Company Profile

Granules India Limited is a fast growing pharmaceutical company with world-class facilities for APIs, PFIs and Finished Dosages, serving customers in over 60 countries. We are committed to excellence in manufacturing, quality and customer service. We are headquartered in Hyderabad with offices in the U.S., U.K., Colombia and China with manufacturing facilities in India and China.

Products: We have focused on a core portfolio. This specialisation enables us to offer an optimal blend of high quality products at competitive costs. We offer products across the value chain comprising APIs, PFIs and FDs.

Scale: We possess the largest PFI facility in the world with an industry-leading batch size of six tons and one of the largest single-site FD facilities in the world. We also have among the largest API capacities for the regulated markets for our respective products.

Quality: Our facilities cater to the demands of quality-conscious customers. Our facilities meet the requirements of some of the most stringent regulatory agencies in the world including the U.S. FDA, MHRA, EDQM, TGA and others.

Customer value: We provide our customers with quality products, large volumes, an extensive range of blends, proactive solutions, a global network of associates and a superior overall price-value proposition. We have our own ANDAs, dossiers and bio-equivalence studies which makes it possible for customers to enter markets with high-quality and cost-effective products. We also possess a strong regulatory affairs department that offers customers support and navigation through regulatory issues.

Alliances: We have bolstered our value proposition through alliances with specialised organisations and institutions including Ajinomoto Omnichem, Hubei Biocause, Heritage Pharmaceutical, IIT Chennai and NUS Singapore.

Relationships: We believe in a partnership approach with our customers. Our goal is to grow with our customers, which is why 50% of our revenues are derived from customer relationships longer than five years.

Presence: We have three facilities in Hyderabad, India and a fourth facility in Jingmen, China. A fifth factory is under construction in Vizag, India through our JV Company, Granules OmniChem. We have sales offices in India, the U.S., UK, Colombia and China to service our customers across 60 countries.

The Pharma Times News Bureau

Recent Posts

World Diabetes Day Survey: Diabetologists and Endocrinologists demand for AI-Based Training and Upskilling in Diabetes Care

 A striking 90% of the 3000 Diabetologists and Endocrinologists surveyed, emphasised the importance of continuous…

3 days ago

Doctors warn diabetes patients about risk of smoking

People who smoke are also at much higher risk of developing diabetes compared to non-smokers…

4 days ago

CPHI & PMEC India Expo: Encouraging affordable solutions in India’s march towards a $130 Billion Pharma Market by 2030

17th edition of CPHI& PMEC India Expo to be held from 26th November-28thNovember 2024, at the India…

4 days ago

Sringeri Sharada Equitas Hospital Revolutionizing Cancer Care with the Launch of Low-cost, High Quality Radiation Therapy

The launch signifies Equitas’ redefined commitment to bring world-class cancer radiation therapy accessible to all.…

5 days ago